1. Home
  2. EDRY vs INKT Comparison

EDRY vs INKT Comparison

Compare EDRY & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDRY
  • INKT
  • Stock Information
  • Founded
  • EDRY 2018
  • INKT 2017
  • Country
  • EDRY Greece
  • INKT United States
  • Employees
  • EDRY N/A
  • INKT N/A
  • Industry
  • EDRY Marine Transportation
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • EDRY Consumer Discretionary
  • INKT Health Care
  • Exchange
  • EDRY Nasdaq
  • INKT Nasdaq
  • Market Cap
  • EDRY 31.7M
  • INKT 36.7M
  • IPO Year
  • EDRY N/A
  • INKT 2021
  • Fundamental
  • Price
  • EDRY $10.70
  • INKT $9.38
  • Analyst Decision
  • EDRY
  • INKT Strong Buy
  • Analyst Count
  • EDRY 0
  • INKT 2
  • Target Price
  • EDRY N/A
  • INKT $6.50
  • AVG Volume (30 Days)
  • EDRY 7.3K
  • INKT 72.2K
  • Earning Date
  • EDRY 02-18-2025
  • INKT 03-20-2025
  • Dividend Yield
  • EDRY N/A
  • INKT N/A
  • EPS Growth
  • EDRY N/A
  • INKT N/A
  • EPS
  • EDRY N/A
  • INKT N/A
  • Revenue
  • EDRY $65,085,280.00
  • INKT N/A
  • Revenue This Year
  • EDRY $34.61
  • INKT N/A
  • Revenue Next Year
  • EDRY $15.93
  • INKT N/A
  • P/E Ratio
  • EDRY N/A
  • INKT N/A
  • Revenue Growth
  • EDRY 39.04
  • INKT N/A
  • 52 Week Low
  • EDRY $10.04
  • INKT $4.56
  • 52 Week High
  • EDRY $24.84
  • INKT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • EDRY 40.02
  • INKT 51.78
  • Support Level
  • EDRY $10.40
  • INKT $7.32
  • Resistance Level
  • EDRY $11.18
  • INKT $13.79
  • Average True Range (ATR)
  • EDRY 0.46
  • INKT 2.00
  • MACD
  • EDRY -0.01
  • INKT 0.05
  • Stochastic Oscillator
  • EDRY 21.43
  • INKT 52.22

About EDRY EuroDry Ltd.

EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: